Management of Acute Hepatic Porphyrias

Classification and Prevention of Acute Attacks

The American Association for the Study of Liver Diseases recommends classifying patients with acute hepatic porphyrias into four subgroups: latent genetic mutation carriers, asymptomatic high excretors, sporadic attack patients, and recurrent attack patients, to determine follow-up and management 2
Avoidance of triggering factors, such as porphyrinogenic drugs, is essential for all patients with acute hepatic porphyrias 1, 3
Limiting alcohol consumption and avoiding smoking are also recommended for patients with acute hepatic porphyrias 2
Maintaining adequate caloric intake and avoiding fasting are crucial for preventing acute attacks in patients with acute hepatic porphyrias 2
Managing stress appropriately is also important for patients with acute hepatic porphyrias 2
Be cautious with hormonal treatments, especially progestins, which can trigger attacks in patients with acute hepatic porphyrias 4

Prophylactic hemin infusions can be administered weekly or once or twice during the luteal phase for menstrual cycle-related attacks in patients with recurrent acute hepatic porphyrias 4, 5
The American Association for the Study of Liver Diseases recommends follow-up frequency based on clinical subgroup, with more frequent monitoring for recurrent attack patients and annual follow-up for sporadic attack patients 4
Screening for complications, such as hepatocellular carcinoma, chronic kidney disease, and hypertension, is essential for patients with acute hepatic porphyrias 4, 6

Pre-conception evaluation is recommended for women with acute hepatic porphyrias, and high-risk obstetrical care is necessary during pregnancy 5
Careful selection of contraceptives is important, as progestin-containing contraceptives may trigger attacks in patients with acute hepatic porphyrias 5
Orthotopic liver transplantation can be curative for patients with severe, disabling attacks or attacks refractory to hemin therapy 4
Renal transplantation benefits patients with advanced renal disease, and combined liver-kidney transplantation may benefit patients with both recurrent attacks and end-stage renal disease 4